» Articles » PMID: 21827904

Spinocerebellar Ataxia Type 2

Overview
Publisher Elsevier
Specialty Neurology
Date 2011 Aug 11
PMID 21827904
Citations 34
Authors
Affiliations
Soon will be listed here.
Citing Articles

Intracerebellar upregulation of Rheb(S16H) ameliorates motor dysfunction in mice with SCA2.

Kim S, Park J, Eo H, Lee G, Park S, Shin M Acta Pharmacol Sin. 2025; .

PMID: 40033054 DOI: 10.1038/s41401-025-01504-y.


Peak width of skeletonized mean diffusivity: a novel biomarker for white matter damage in spinocerebellar ataxia type 2.

Chen N, Peng J, Xiong F, Tu Y Neuroradiology. 2024; 67(1):183-189.

PMID: 39535589 DOI: 10.1007/s00234-024-03499-5.


Post-symptomatic administration of hMSCs exerts therapeutic effects in SCA2 mice.

Kim S, Sharma C, Hong J, Kim J, Nam Y, Kim M Stem Cell Res Ther. 2024; 15(1):411.

PMID: 39521966 PMC: 11550562. DOI: 10.1186/s13287-024-04020-8.


Progressive Apraxia of Speech as a Manifestation of Spinocerebellar Ataxia 2: Case Report.

Blazek A, Meade G, Jackson L, Gavrilova R, Stierwalt J, Martinez-Thompson J Neurol Genet. 2024; 10(6):e200202.

PMID: 39512795 PMC: 11543266. DOI: 10.1212/NXG.0000000000200202.


Serum S100β Levels Are Linked with Cognitive Decline and Peripheral Inflammation in Spinocerebellar Ataxia Type 2.

Vazquez-Mojena Y, Rodriguez-Labrada R, Cordova-Rodriguez Y, Dominguez-Barrios Y, Fernandez-Herrera M, Leon-Arcia K Cerebellum. 2024; 23(4):1509-1520.

PMID: 38347269 DOI: 10.1007/s12311-024-01665-2.